| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/21/2008 | CN101182321A Indolizine heterocyclic nitrogen naphthoquinone derivatives as well as preparation method and anticancer use thereof |
| 05/21/2008 | CN100389115C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 05/20/2008 | US7375227 May be combined with ACE inhibitors, angiotensin or endothelin receptor antagonists, vasopressin antagonists, alpha- and beta-adrenergic antagonists, TNFalpha antagonists, and peroxisome proliferator activator receptor modulators; cardiovascular, renal, metabolic, pulmonary and psychological disorders |
| 05/20/2008 | US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2205664C Indole derivatives and medicinal use thereof |
| 05/15/2008 | WO2008058261A1 Substituted 3-isobutyl-9, 10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-2-ol compounds and methods relating thereto |
| 05/15/2008 | WO2008058037A1 Compounds and compositions as protein kinase inhibitors |
| 05/15/2008 | WO2008057940A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 05/15/2008 | WO2008057938A1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 05/15/2008 | WO2008057856A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 05/15/2008 | WO2008056335A1 5-hydroxymethyl-oxazolidin-2-one derivatives |
| 05/15/2008 | WO2008056151A1 Topical formulations |
| 05/15/2008 | WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 05/15/2008 | WO2008055842A1 Substituted 6-phenyl-pyrido [2,3-d] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
| 05/15/2008 | WO2008055814A2 Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 05/15/2008 | WO2008033464A3 Azetidinone derivatives for the treatment of disorders of the lipid metabolism |
| 05/15/2008 | WO2008008310A3 Tyrosine kinase inhibitors |
| 05/15/2008 | WO2007064914A8 5-(arylsulfonyl)-pyrazolopiperidines |
| 05/15/2008 | WO2007052104A8 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1h-[1,8]naphthyridin-2-one |
| 05/15/2008 | US20080114052 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/15/2008 | US20080114026 1-[4-(4-chloro-2-methyl-3H-imidazo[4,5-c]pyridin-3-ylmethyl)phenyl]-3-(2-fluoro-5-trifluoromethylphenyl)urea; antitumor, antiinflammatory agent, autoimmune diseases; kinase signal transduction (tyrosine, Raf) mediated diseases: solid tumors, leukemia, psoriasis, arthritis, endometriosis, |
| 05/15/2008 | US20080114024 such as 5-(3-Aminopropylamino)-2-benzyloxy-7-(4-methoxyphenyl)-[1,6]naphthyridine; spleen tyrosine kinase inhibitor; controlling activation of mast cells; antiallergens, antiinflamamtory agents; asthma, chronic obstructive pulmonary disease (COPD), Crohn's disease, bronchitis, conjunctivitis, psoriasis |
| 05/15/2008 | US20080114023 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 05/15/2008 | US20080114022 (1-Benzyl-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-acetic acid; chemoattractant receptor-homologous molecule expressed on helper T-cells antagonist; antiinflammatory agent, antiallergen; obstructive airways disease |
| 05/15/2008 | US20080114019 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 05/15/2008 | US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/15/2008 | US20080114017 2-Methyl-1-thioxo-10-(3-trifluoromethoxy-phenyl)-1,2,3a,4,9,10-hexahydro-2,9,10a-triaza-cyclopenta[b]fluoren-3-one; anticarcinogenic agent; solid tumor and leukemia; cell-cycle specific mode of action: DNA replication or interfering directly with basic cellular molecules like DNA |
| 05/15/2008 | US20080114016 5-(3-aminopropyl)-3-methyl-2,5,7,8,9,10-hexahydro-4H-benzo[g]pyrazolo[4,3-c]quinolin-4-one; anticarcinogenic agent; enhance DNA damaging agents by initiating mitosis before DNA repair is complete and thereby causing tumor cell death; in preparation of a anticancer medicaments |
| 05/15/2008 | US20080114012 1-(1,3-benzodioxol-5-yl)-N-(3,5-dimethylphenyl)-1,9-dihydrospiro[ beta -carboline-4,1'-cyclopropane]-2(3H)-carboxamide; mitochondrial benzodiazepine receptor modulator; digestive system disease caused by stress: irritable bowel syndrome, ulcerative colitis, or Crohn's disease |
| 05/15/2008 | US20080114007 8-indan-5-yl-5-oxo-2-(3-piperazin-1-yl-phenylamino)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid isopropylamide; antiinflammatory, anticarcinogenic agent, cardiovascular disease; glomerulonephritis, immune nephritis, rheumatoid arthritis, asthma, pancreatitis, HIV infection, psoriasis |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080113991 Pyridopyrazines and the use thereof as kinase inhibitors |
| 05/15/2008 | US20080113971 improved potency; reduced undesirable side effects; pain, inflammation, arthritis etc; ethyl 1-(2-aminoethyl)-3-pyridin-4-yl-1H-pyrazole-5-carboxylate dihydrochloride |
| 05/15/2008 | US20080113967 Enzyme modulators and treatments |
| 05/15/2008 | US20080113963 Prepared by submitting benzimidazole compound to a cyclization reaction; gastric secretion inhibiting and gastric and intestinal protective action properties; for gastrointestinal disorders; for example, 2,3-Dimethyl-8-phenyl-3,6,7,8-tetrahydro-chromeno[7,8-a]imidazole-5-carboxylic acid dimethylamide |
| 05/15/2008 | US20080113962 Condensed Tricyclic Benzimidazoles For the Treatment of Gastrointestinal Disorders |
| 05/15/2008 | US20080113957 azetidine-2-imines or fused ring derivatives thereof; inhibiting aspartyl proteases including beta-secretase; cardiovascular diseases, cognitive and neurodegenerative diseases such as Alzheimer's, inhibiting Human Immunodeficiency Virus, plasmepins, cathepsin D and protozoal enzymes |
| 05/15/2008 | US20080109989 Stacking wall panel system and methods of installation and use |
| 05/15/2008 | CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 05/15/2008 | CA2668731A1 Kinase inhibitors and methods for using the same |
| 05/15/2008 | CA2668689A1 Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto |
| 05/15/2008 | CA2668429A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 05/15/2008 | CA2668280A1 5-hydroxymethyl-oxazolidin-2-one derivatives |
| 05/15/2008 | CA2668190A1 Compounds and compositions as protein kinase inhibitors |
| 05/15/2008 | CA2667679A1 Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 05/15/2008 | CA2663925A1 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes |
| 05/14/2008 | EP1921078A1 Multikinase inhibitor |
| 05/14/2008 | EP1921075A2 A process for the preparation of pyridine-methylsulfinyl compounds |
| 05/14/2008 | EP1920654A1 Novel pyridopyrazine N-oxides |
| 05/14/2008 | EP1919924A2 Compounds and compositions as protein kinase inhibitors |
| 05/14/2008 | EP1919922A1 Method for synthesizing spiro quaternary ammonium systems |
| 05/14/2008 | EP1919916A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 05/14/2008 | EP1919913A2 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919911A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 05/14/2008 | EP1919910A1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 05/14/2008 | EP1919872A2 Chemical compounds |
| 05/14/2008 | EP1919482A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use |
| 05/14/2008 | EP1919475A1 Tetrahydro- beta-carbolin-sulfonamide derivatives as 5-ht6 ligands |
| 05/14/2008 | EP1919474A1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators |
| 05/14/2008 | EP1919470A1 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS |
| 05/14/2008 | EP1824852B1 1,2,3,3a,8,8a-hexahydro-2,7a-diaza-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders |
| 05/14/2008 | EP1551831A4 Method for preparing risperidone |
| 05/14/2008 | EP1513841B1 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | CN101180299A Acetylenyl-pyrazolo-pvrimidine derivatives as MGLUR2 antagonists |
| 05/14/2008 | CN100387598C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/13/2008 | US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl |
| 05/13/2008 | US7371864 3-(1-hydroxy-1-methyl-ethyl)-1-(4-methoxy-phenyl)-6-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one for treating thromboembolic disorders |
| 05/13/2008 | US7371863 Method for manufacture of THIP |
| 05/13/2008 | US7371862 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/13/2008 | US7371861 Process for preparing ring-fluorinated aromatics |
| 05/13/2008 | US7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/13/2008 | US7371757 Fused heterocycles as inhibitors of glutamate racemase(MURI) |
| 05/13/2008 | US7371752 such as 5-(4-Fluorophenyl)-7-[(2-pyridyl)-methyloxy]-thieno[3,2-b]pyridine, used as prodrugs or antagonists for GABA receptors, in diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and epileptic disorders, as cognition activators and as antidotes to benzodiazepines |
| 05/13/2008 | US7371750 Compounds and compositions as protein kinase inhibitors |
| 05/13/2008 | US7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/13/2008 | US7371470 Pyran derivative |
| 05/13/2008 | CA2196995C Spiro-azabicyclic compounds useful in therapy |
| 05/08/2008 | WO2008055013A2 5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase |
| 05/08/2008 | WO2008054795A2 Triazolopyrimidine derivatives as adp p2y12 receptor antagonists |
| 05/08/2008 | WO2008054749A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 05/08/2008 | WO2008054702A1 Anilinopiperazine derivatives and methods of use thereof |
| 05/08/2008 | WO2008054701A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 05/08/2008 | WO2008054252A1 Pharmacologically active n,n'-substituted 3,7-diazabicyclo [3.3.1] nonanes, pharmaceutical compositions based thereon and a method for the use thereof |
| 05/08/2008 | WO2008054024A1 Novel photosensitizer and photovoltaic device |
| 05/08/2008 | WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton |
| 05/08/2008 | WO2008053324A1 An improved process for the preparation of gemifloxacin mesylate |
| 05/08/2008 | WO2008053319A1 Amide resorcinol compounds |
| 05/08/2008 | WO2008053158A1 Inhibitors of p38 mitogen-activated protein kinase |
| 05/08/2008 | WO2008053031A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 05/08/2008 | WO2008052927A1 Heptarylene and octarylene tetracarboxylic acid diimides, and production thereof |
| 05/08/2008 | WO2008052441A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |